The aim of this study was to identify hereditary and acquired risk-factors as they are related to the occurrence of stroke in children. We identified 21 children with stroke. A search of the Factor V Leiden mutation, the Factor II G20210A variant, and the thermolabile variant of methylenetetrahydrofolate reductase was performed in patients and in a control group (n = 115).We identified risk factors of acquired ...
We report the results of 10 years of prophylactic fresh-frozen plasma (FFP) infusion therapy in a 14-year-old girl with chronic relapsing thrombotic thrombocytopenic purpura (TTP), in whom a severe congenital von Willebrand factor (VWF)-cleaving protease deficiency has been documented. Severe haemolytic crises triggered by infections were prevented and her present renal and neurological functions have been pres...
La resistencia a la proteína C activada es la alteración hereditaria de la coagulación más frecuente. La mayoría de los casos resulta de la mutación Arg506®Gln en el gen del factor V, y se caracteriza por una respuesta reducida a la acción anticoagulante de la proteína C activada. Caso clínico. Descibimos el caso de un niño de 6 años, obeso, con hemiparesia derecha de instalación súbita por infarto en la hemipr...
Financiadores do RCAAP | |||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |